Cardiac tumors screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
*The diagnostic accuracy of echocardiography is 80%. After initial diagnosis on TTE, cardiac CT/MRI are commonly used to stage and further evaluate the tumors.<ref name="pmid29183343">{{cite journal| author=Nomoto N, Tani T, Konda T, Kim K, Kitai T, Ota M | display-authors=etal| title=Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study. | journal=J Cardiothorac Surg | year= 2017 | volume= 12 | issue= 1 | pages= 103 | pmid=29183343 | doi=10.1186/s13019-017-0672-7 | pmc=5704631 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29183343 }} </ref> | *The diagnostic accuracy of echocardiography is 80%. After initial diagnosis on TTE, cardiac CT/MRI are commonly used to stage and further evaluate the tumors.<ref name="pmid29183343">{{cite journal| author=Nomoto N, Tani T, Konda T, Kim K, Kitai T, Ota M | display-authors=etal| title=Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study. | journal=J Cardiothorac Surg | year= 2017 | volume= 12 | issue= 1 | pages= 103 | pmid=29183343 | doi=10.1186/s13019-017-0672-7 | pmc=5704631 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29183343 }} </ref> | ||
*In patients undergoing myxoma resection, routine echocardiography screening should be performed for the rest of their lives.<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042 }} </ref> | *In patients undergoing myxoma resection, routine echocardiography screening should be performed for the rest of their lives.<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042 }} </ref> | ||
*Pediatric patients with [[tuberous sclerosis]] require monitoring because of the risk of rhabdomyoma. | |||
**At the initial diagnosis, electrocardiograms and echocardiography must be performed on all kids with tuberous sclerosis. | |||
**Periodic monitoring of electrocardiograms are advised every three to five years due to the lifetime risk of arrhythmia regardless of the presence early-onset cardiac rhabdomyoma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 00:39, 16 May 2022
|
Cardiac tumors Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tumors screening On the Web |
|
American Roentgen Ray Society Images of Cardiac tumors screening |
|
Risk calculators and risk factors for Cardiac tumors screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Template:Dj
Overview
Screening
- According to the USPSTF, routine screening for cardiac tumors is not recommended.
- Transthoracic echocardiography (TTE) continues to be the method of choice for screening for cardiac malignancies. Transesophageal echocardiogram (TEE) is commonly used for valvular lesions.[1]
- Emerging technologies such as contrast echocardiography and three-dimensional echocardiogram may substantially improve the diagnostic accuracy of echocardiography.[2]
- The diagnostic accuracy of echocardiography is 80%. After initial diagnosis on TTE, cardiac CT/MRI are commonly used to stage and further evaluate the tumors.[3]
- In patients undergoing myxoma resection, routine echocardiography screening should be performed for the rest of their lives.[1]
- Pediatric patients with tuberous sclerosis require monitoring because of the risk of rhabdomyoma.
- At the initial diagnosis, electrocardiograms and echocardiography must be performed on all kids with tuberous sclerosis.
- Periodic monitoring of electrocardiograms are advised every three to five years due to the lifetime risk of arrhythmia regardless of the presence early-onset cardiac rhabdomyoma.
References
- ↑ 1.0 1.1 Lamba G, Frishman WH (2012). "Cardiac and pericardial tumors". Cardiol Rev. 20 (5): 237–52. doi:10.1097/CRD.0b013e31825603e7. PMID 22447042.
- ↑ Mankad R, Herrmann J (2016). "Cardiac tumors: echo assessment". Echo Res Pract. 3 (4): R65–R77. doi:10.1530/ERP-16-0035. PMC 5292983. PMID 27600455.
- ↑ Nomoto N, Tani T, Konda T, Kim K, Kitai T, Ota M; et al. (2017). "Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study". J Cardiothorac Surg. 12 (1): 103. doi:10.1186/s13019-017-0672-7. PMC 5704631. PMID 29183343.